SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-214243
Filing Date
2011-08-08
Accepted
2011-08-08 16:14:16
Documents
15
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 649600
2 DIRECTOR COMPENSATION AND STOCK OWNERSHIP POLICY dex1024.htm EX-10.24 17619
3 LICENSE AGREEMENT dex1025.htm EX-10.25 250361
4 SUPPLY AGREEMENT dex1026.htm EX-10.26 56994
5 SUPPLY AGREEMENT dex1027.htm EX-10.27 309635
6 CERTIFICATION dex311.htm EX-31.1 6581
7 CERTIFICATION dex312.htm EX-31.2 6585
8 CERTIFICATION dex321.htm EX-32.1 4158
9 CERTIFICATION dex322.htm EX-32.2 4161
  Complete submission text file 0001193125-11-214243.txt   3383314

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT lgnd-20110630.xml EX-101.INS 389799
11 XBRL TAXONOMY EXTENSION SCHEMA lgnd-20110630.xsd EX-101.SCH 12007
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lgnd-20110630_cal.xml EX-101.CAL 53576
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lgnd-20110630_def.xml EX-101.DEF 19495
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE lgnd-20110630_lab.xml EX-101.LAB 142459
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lgnd-20110630_pre.xml EX-101.PRE 95182
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 111017368
SIC: 2834 Pharmaceutical Preparations